Search Results - R. E. Kazakov
- Showing 1 - 12 results of 12
-
1
-
2
PHARMACOGENETICS OF ORGANIC CATION TRANSPORTERS by V. A. Evteev, R. E. Kazakov, O. A. Muslimova, E. Yu. Demchenkova
Published 2018-06-01
Article -
3
-
4
INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANE... by K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
Published 2015-09-01
Article -
5
-
6
-
7
-
8
CYTOCHROME P450 (CYP2C9) ACTIVENESS, EVALUATED VIA LOSARTAN TEST, AS PREDICTION MARKER FOR THE WARFARIN TREATMENT DOSAGE CHOICE IN PATIENTS WITH DELAYED OUTCOMES AFTER HEART VALVES... by S. M. Arslanbekova, D. A. Sychev, K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, N. M. Magomedova, E. Z. Golukhova
Published 2015-10-01
Article -
9
-
10
-
11
Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis by A. B. Prokofiev, S. A. Belkov, R. E. Kazakov, N. G. Berdnikova, T. A. Rodina, E. S. Melnikov, A. A. Danko, N. E. Voronova, R. Z. Vafina, A. V. Zavtoniev, D. V. Tsyganko, E. Yu. Demchenkova
Published 2022-07-01
Article -
12
Pharmacogenetics and Inflammatory Bowel Diseases in Adults and Children: Diagnosis and Treatment Prospects by S. Yu. Serebrova, A. B. Prokofiev, M. V. Zhuravleva, R. E. Kazakov, I. V. Suchinava, G. I. Gorodetskaya, N. N. Eremenko, N. B. Lazareva, L. R. Galstyan, E. A. Smolyarchuk, D. O. Kurguzova, A. O. Barkov
Published 2020-05-01
Article